Clinical Trial Update: Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy [Phase 3]

View source ↗

Summary

A status update on a Phase 3 clinical trial evaluating erythropoietin for neonatal hypoxic-ischemic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Assiut University | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 3 | Status: UNKNOWN